FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308402871> ?p ?o ?g. }

• W4308402871 abstract "<h3>Background</h3> Within Diffuse Midline Gliomas, Diffuse Intrinsic Pontine Glioma (DIPG) is the principal cause of non-accidental pediatric deaths. Although gold-standard treatments have improved, the outcome for children with DIPGs remains poor pointing to the need for alternative therapies. In this sense, we have previously demonstrated that the oncolytic adenovirus Delta-24-RGD (which has already shown safety and feasibility in DIPG patients) is able to recruit T cells into the tumor. However, such as T-lymphocyte infiltration rapidly acquires an exhausted phenotype that prevents from achieving long-term anti-tumor responses. Therefore, we decided to improve this therapy by combining the Delta-24-RGD with the activation of the costimulatory receptor CD40, which is known to increase antigen presentation and enable T-cell priming. <h3>Methods</h3> To determine anti-tumor efficacy, we treated immunocompetent and immunodeficient mice bearing orthotopic DIPG tumors with an intratumoral injection including the Delta-24-RGD and a CD40 agonistic monoclonal antibody. Survival and toxicity were monitored after treatment and the changes in the tumor immune microenvironment were analyzed by flow cytometry, immunofluorescence, and RNA sequencing. Long-term survivors were rechallenged with primary tumor cells to study the development of anti-tumor immunological memory. <h3>Results</h3> The combination therapy is safe and extends survival of immunocompetent treated mice as compared to single treatments or non-treated mice, resulting in 40% of complete responses. In addition, mice that rejected the tumor were able to control the growth of a rechallenge with the primary cells indicating the development of long-term anti-tumor immunity. This, together with the lack of effect observed in immunodeficient mice evidences a key role of the adaptive immune system in the anti-tumor response. We found that the combination remodels the tumor context towards a proinflammatory scenario with an increase of proinflammatory chemokines, proliferating T lymphocytes and activated dendritic cells, which express high levels of the CD40 receptor. In addition, the blocking of CSF1R (mainly expressed by microglia/macrophages) avoids the recruitment of dendritic cells into the tumor and abrogates the anti-tumor effect observed upon the combination of Delta-24-RGD and anti-CD40. <h3>Conclusions</h3> Our results show that the combination of Delta-24-RGD with the stimulation of CD40 is safe, has a potent and long-term anti-tumor effect and promotes a proinflammatory tumor microenvironment. We believe that these results can be translational and open the door for a future innovative clinical trial. <h3>Ethics Approval</h3> The study was approved by the University of Navarra9s Ethics Committee for Animal Experimentation (CEEA), approval number 068-20" @default.
• W4308402871 created "2022-11-11" @default.
• W4308402871 creator A5000183191 @default.
• W4308402871 creator A5005329272 @default.
• W4308402871 creator A5024660935 @default.
• W4308402871 creator A5038432727 @default.
• W4308402871 creator A5038824430 @default.
• W4308402871 creator A5043322499 @default.
• W4308402871 creator A5059741602 @default.
• W4308402871 creator A5064785619 @default.
• W4308402871 creator A5072773574 @default.
• W4308402871 creator A5077791294 @default.
• W4308402871 creator A5081301268 @default.
• W4308402871 creator A5089189433 @default.
• W4308402871 date "2022-11-01" @default.
• W4308402871 modified "2023-10-18" @default.
• W4308402871 title "836 Activating the antigen presenting cells to improve virotherapy efficacy in diffuse midline gliomas" @default.
• W4308402871 doi "https://doi.org/10.1136/jitc-2022-sitc2022.0836" @default.
• W4308402871 hasPublicationYear "2022" @default.
• W4308402871 type Work @default.
• W4308402871 citedByCount "0" @default.
• W4308402871 crossrefType "proceedings-article" @default.
• W4308402871 hasAuthorship W4308402871A5000183191 @default.
• W4308402871 hasAuthorship W4308402871A5005329272 @default.
• W4308402871 hasAuthorship W4308402871A5024660935 @default.
• W4308402871 hasAuthorship W4308402871A5038432727 @default.
• W4308402871 hasAuthorship W4308402871A5038824430 @default.
• W4308402871 hasAuthorship W4308402871A5043322499 @default.
• W4308402871 hasAuthorship W4308402871A5059741602 @default.
• W4308402871 hasAuthorship W4308402871A5064785619 @default.
• W4308402871 hasAuthorship W4308402871A5072773574 @default.
• W4308402871 hasAuthorship W4308402871A5077791294 @default.
• W4308402871 hasAuthorship W4308402871A5081301268 @default.
• W4308402871 hasAuthorship W4308402871A5089189433 @default.
• W4308402871 hasBestOaLocation W43084028711 @default.
• W4308402871 hasConcept C147483822 @default.
• W4308402871 hasConcept C203014093 @default.
• W4308402871 hasConcept C2776107976 @default.
• W4308402871 hasConcept C2776662205 @default.
• W4308402871 hasConcept C2777701055 @default.
• W4308402871 hasConcept C2778227246 @default.
• W4308402871 hasConcept C3875195 @default.
• W4308402871 hasConcept C502942594 @default.
• W4308402871 hasConcept C71924100 @default.
• W4308402871 hasConcept C82210918 @default.
• W4308402871 hasConcept C8891405 @default.
• W4308402871 hasConceptScore W4308402871C147483822 @default.
• W4308402871 hasConceptScore W4308402871C203014093 @default.
• W4308402871 hasConceptScore W4308402871C2776107976 @default.
• W4308402871 hasConceptScore W4308402871C2776662205 @default.
• W4308402871 hasConceptScore W4308402871C2777701055 @default.
• W4308402871 hasConceptScore W4308402871C2778227246 @default.
• W4308402871 hasConceptScore W4308402871C3875195 @default.
• W4308402871 hasConceptScore W4308402871C502942594 @default.
• W4308402871 hasConceptScore W4308402871C71924100 @default.
• W4308402871 hasConceptScore W4308402871C82210918 @default.
• W4308402871 hasConceptScore W4308402871C8891405 @default.
• W4308402871 hasLocation W43084028711 @default.
• W4308402871 hasOpenAccess W4308402871 @default.
• W4308402871 hasPrimaryLocation W43084028711 @default.
• W4308402871 hasRelatedWork W3002319954 @default.
• W4308402871 hasRelatedWork W3013943237 @default.
• W4308402871 hasRelatedWork W3029072430 @default.
• W4308402871 hasRelatedWork W3132887062 @default.
• W4308402871 hasRelatedWork W3177607563 @default.
• W4308402871 hasRelatedWork W3202927769 @default.
• W4308402871 hasRelatedWork W4293101997 @default.
• W4308402871 hasRelatedWork W4308917956 @default.
• W4308402871 hasRelatedWork W4361282374 @default.
• W4308402871 hasRelatedWork W4377097667 @default.
• W4308402871 isParatext "false" @default.
• W4308402871 isRetracted "false" @default.
• W4308402871 workType "article" @default.